{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:12:03Z","timestamp":1792293123520,"version":"4.4.0"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.01207","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T07:06:37Z","timestamp":1592550397000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":59,"title":["Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma"],"prefix":"10.3389","volume":"11","author":[{"given":"Kunihiro","family":"Tsukasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambroise","family":"Mar\u00e7ais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihab","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/bmt.2014.143","article-title":"Outcome of patients with HTLV-1-associated adult T-cell leukemia\/lymphoma after SCT: a retrospective study by the EBMT LWP.","volume":"49","author":"Bazarbachi","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"B2","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1097\/00042560-199600001-00028","article-title":"Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia\/lymphoma patients.","volume":"13","author":"Bazarbachi","year":"1996","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1200\/jco.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes.","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/bmt.2010.92","article-title":"Long-term outcomes after hematopoietic SCT for adult T-cell leukemia\/lymphoma: results of prospective trials.","volume":"46","author":"Choi","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"B5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised adult T-cell leukemia-lymphoma international consensus meeting report.","volume":"37","author":"Cook Lucy","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1182\/blood-2006-01-0067","article-title":"Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence.","volume":"108","author":"Datta","year":"2006","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1200\/jco.2013.54.2456","article-title":"Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study.","volume":"32","author":"Fanale","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/bmt.2015.265","article-title":"Early application of related stem-cell transplantation might improve clinical outcome in adult T-cell leukemia\/lymphoma.","volume":"51","author":"Fuji","year":"","journal-title":"Bone Marrow Transplant."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/jco.2016.67.8250","article-title":"Pretransplantation anti-CCR4 antibody mogamulizumab against adult T-cell leukemia\/lymphoma is associated with significantly increased risks of severe and corticosteroid-refractory graft-versus-host disease, nonrelapse mortality, and overall mortality.","volume":"34","author":"Fuji","year":"","journal-title":"J. Clin. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41409-017-0082-4","article-title":"Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis.","volume":"53","author":"Fuji","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"B11","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/sj.leu.2403682","article-title":"Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia\/lymphoma.","volume":"19","author":"Fukushima","year":"2005","journal-title":"Leukemia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/bjh.12962","article-title":"Japan clinical oncology group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A).","volume":"166","author":"Fukushima","year":"2014","journal-title":"Br. J. Haematol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1056\/nejm199506293322603","article-title":"Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.","volume":"332","author":"Gill","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/sj.thj.6200195","article-title":"French ATL therapy group. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia\/lymphoma.","volume":"3","author":"Hermine","year":"2002","journal-title":"Hematol. J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/nejm199506293322604","article-title":"Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa.","volume":"332","author":"Hermine","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"B16","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study.","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1200\/JCO.2011.35.5578","article-title":"Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia\/lymphoma.","volume":"29","author":"Hodson","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/bmt.2015.315","article-title":"Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality.","volume":"51","author":"Inoue","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41409-018-0139-z","article-title":"Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia\/lymphoma.","volume":"53","author":"Inoue","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1200\/jco.2016.67.7732","article-title":"Multicenter phase II study of lenalidomide in relapsed or recurrent adult T-cell leukemia\/lymphoma: ATLL-002.","volume":"34","author":"Ishida","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1182\/blood-2012-03-414490","article-title":"Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study.","volume":"120","author":"Ishida","year":"","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1200\/jco.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study.","volume":"30","author":"Ishida","year":"","journal-title":"J. Clin. Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bjh.13338","article-title":"Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.","volume":"169","author":"Ishida","year":"2015","journal-title":"Br. J. Haematol."},{"key":"B25","first-page":"3625","article-title":"Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome.","volume":"9","author":"Ishida","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.bbmt.2013.01.011","article-title":"Distinct clinical features of infectious complications in adult T cell leukemia\/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group.","volume":"19","author":"Itonaga","year":"","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1182\/blood-2012-07-444372","article-title":"Treatment of relapsed adult T-cell leukemia\/lymphoma after allogeneic hematopoietic stem cell transplantation: the nagasaki transplant group experience.","volume":"121","author":"Itonaga","year":"","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","article-title":"Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan.","volume":"116","author":"Iwanaga","year":"2010","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00322","article-title":"Adult T-cell leukemia: a review of epidemiological evidence.","volume":"3","author":"Iwanaga","year":"2012","journal-title":"Front. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1002\/1097-0142(19940601)73:11<2753::aid-cncr2820731117>3.0.co;2-x","article-title":"Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia.","volume":"73","author":"Kamihira","year":"1994","journal-title":"Cancer"},{"key":"B31","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma.","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat. Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.bbmt.2014.08.012","article-title":"Treatment of adult T-cell leukemia\/lymphoma with cord blood transplantation: a Japanese nationwide retrospective survey.","volume":"20","author":"Kato","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbmt.2006.09.002","article-title":"Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia\/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program.","volume":"13","author":"Kato","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/hon.2558","article-title":"The outcome and characteristics of patients with relapsed adult T cell leukemia\/lymphoma after allogeneic hematopoietic stem cell transplantation.","volume":"37","author":"Kato","year":"2019","journal-title":"Hematol. Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1182\/blood-2017-01-757542","article-title":"Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma.","volume":"130","author":"Katsuya","year":"2017","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1200\/JCO.2011.38.2101","article-title":"Prognostic index for acute- and lymphoma-type adult T-cell leukemia\/lymphoma.","volume":"30","author":"Katsuya","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-10-52","article-title":"Interferon-\u03b1 (IFN-\u03b1) suppresses HTLV-1 gene expression and cell cycling, while IFN-\u03b1 combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells.","volume":"10","author":"Kinpara","year":"2013","journal-title":"Retrovirology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1182\/bloodadvances.2016001370","article-title":"Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-alpha.","volume":"1","author":"Macchi","year":"2017","journal-title":"Blood Adv."},{"key":"B39","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1182\/bloodadvances.2017011106","article-title":"Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States.","volume":"2","author":"Malpica","year":"2018","journal-title":"Blood Adv."},{"key":"B40","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1046\/j.1365-2141.2001.02794.x","article-title":"Interferon alpha and zidovudine therapy in adult T-cellleukaemia lymphoma: response and outcome in 15 patients.","volume":"113","author":"Matutes","year":"2001","journal-title":"Br. J. Haematol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1084\/jem.20140987","article-title":"Gain-of-function CCR4 mutations in adult T cell leukemia\/lymphoma.","volume":"211","author":"Nakagawa","year":"2014","journal-title":"J. Exp. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/bmt.2014.204","article-title":"High incidence of CMV infection in adult T-cell leukemia\/lymphoma patients after allogeneic hematopoietic stem cell transplantation.","volume":"49","author":"Nakano","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1038\/sj.onc.1210984","article-title":"Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia.","volume":"27","author":"Nakayama","year":"2008","journal-title":"Oncogene"},{"key":"B44","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3390\/v3060750","article-title":"Controversies in targeted therapy of adult T cell leukemia\/lymphoma: ON target or OFF target effects?","volume":"3","author":"Nasr","year":"2011","journal-title":"Viruses"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1111\/cas.13398","article-title":"Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: a nationwide survey.","volume":"108","author":"Nosaka","year":"2017","journal-title":"Cancer Sci."},{"key":"B46","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(15)00284-7","article-title":"Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study.","volume":"3","author":"Ogura","year":"2016","journal-title":"Lancet Haematol."},{"key":"B47","first-page":"281","article-title":"Adult T-cell leukemia\/lymphoma","author":"Ohshima","year":"2017","journal-title":"WHO Classification of Tumour of Haemaopoietic and Lymphoid Tissues"},{"key":"B48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1349-7006.1989.tb02289.x","article-title":"Multi-step carcinogenesis model for adult T-cell leukemia.","volume":"80","author":"Okamoto","year":"1989","journal-title":"Jpn. J. Cancer Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1182\/blood-2004-11-4193","article-title":"Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia\/lymphoma.","volume":"105","author":"Okamura","year":"2005","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3324\/haematol.2018.205096","article-title":"Mogamulizumab versus investigator\u2019s choice of chemotherapy regimen in relapsed\/refractory adult T-cell leukemia\/lymphoma.","volume":"104","author":"Phillips","year":"2019","journal-title":"Haematologica"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/s1473-3099(16)30252-3","article-title":"Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis.","volume":"16","author":"Satake","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jmv.23181","article-title":"Current prevalence of HTLV-1 in Japan as determined by screening of blood donors.","volume":"84","author":"Satake","year":"2012","journal-title":"J. Med. Virol."},{"key":"B53","doi-asserted-by":"crossref","first-page":"E143","DOI":"10.1002\/ajh.25438","article-title":"Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia\/lymphoma.","volume":"94","author":"Sawayama","year":"2019","journal-title":"Am. J. Hematol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T- cell leukaemia-lymphoma: a report from the lymphoma study group (1984- 87).","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br. J. Haematol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0145-2126(91)90087-a","article-title":"Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. lymphoma study group (1984-1987).","volume":"15","year":"1991","journal-title":"Leuk. Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1200\/jco.1988.6.1.128","article-title":"Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin\u2019s lymphoma treated with VEPA or VEPA-M.","volume":"6","author":"Shimoyama","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"B57","first-page":"227","article-title":"Final results of cooperative study of VEPA [vincristine, cyclophosphamide (endoxan), prednisolone and adriamycin] therapy in advanced adult non-Hodgkin\u2019s lymphoma: relation between T- or B-cell phenotype and response.","volume":"12","author":"Shimoyama","year":"1982","journal-title":"Jpn. J. Clin. Oncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1158\/0008-5472.can-16-0361","article-title":"HTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and Proliferation.","volume":"76","author":"Sugata","year":"2016","journal-title":"Cancer Res."},{"key":"B59","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.bbmt.2016.05.017","article-title":"Mogamulizumab treatment prior to allogeneic hematopoietic stem cell transplantation induces severe acute graft-versus-host disease.","volume":"22","author":"Sugio","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B60","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/ijc.2910450206","article-title":"The 4th nationwide study of adult T-cell leukemia\/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. T- and B-cell malignancy study group.","volume":"45","author":"Tajima","year":"1990","journal-title":"Int. J. Cancer"},{"key":"B61","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1182\/blood-2009-09-242347","article-title":"Long-term study of indolent adult T-cell leukemia-lymphoma.","volume":"115","author":"Takasaki","year":"2010","journal-title":"Blood"},{"key":"B62","author":"Takatsuki","year":"1994","journal-title":"Adult T-Cell Leukemia."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1056\/nejmc053295","article-title":"Donor-derived T-cell leukemia after bone marrow transplantation.","volume":"354","author":"Tamaki","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/nejm199511093331911","article-title":"Interferon alfa and zidovudine in adult T-cell leukemia-lymphoma (correspondence).","volume":"333","author":"Tobinai","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"B65","first-page":"164","article-title":"Phase I study of YK-176 (2-deoxycoformycin) in patients with adult T-cell leukemia\u2013lymphoma.","volume":"22","author":"Tobinai","year":"1992","journal-title":"Jpn. J. Clin. Oncol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/jco.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: A proposal from an international consensus meeting.","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/1346-8138.12374","article-title":"Meeting report on the possible proposal of an extranodal primary cutaneous variant in the lymphoma type of adult T-cell leukemia-lymphoma.","volume":"41","author":"Tsukasaki","year":"2014","journal-title":"J. Dermatol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.bmt.1701533","article-title":"Poor outcome of autologous stem cell transplantation for adult T cell leukemia\/lymphoma: a case report and review of the literature.","volume":"23","author":"Tsukasaki","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"B69","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/jjco\/hyr168","article-title":"Lymphoma study group of JCOG.","volume":"42","author":"Tsukasaki","year":"2012","journal-title":"Jpn. J. Clin. Oncol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/bf02983215","article-title":"Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia \u2013lymphoma: japan clinical oncology group study (JCOG9109).","volume":"77","author":"Tsukasaki","year":"2003","journal-title":"Int. J. Hematol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1200\/jco.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia\u2013lymphoma: japan clinical oncology group study JCOG9801.","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/sj.bmt.1702731","article-title":"Improved outcome of adult T cell leukemia\/lymphoma with allogeneic hematopoietic stem cell transplantation.","volume":"27","author":"Utsunomiya","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"B73","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/jco.2008.16.4558","article-title":"International T-Cell Lymphoma Project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes.","volume":"26","author":"Vose","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","article-title":"A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukemia-lymphoma (ATL): japan clinical oncology group (JCOG) study 9303.","volume":"113","author":"Yamada","year":"2001","journal-title":"Br. J. Haematol."},{"key":"B75","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0950-3536(05)80183-0","article-title":"Adult T cell leukaemia-lymphoma.","volume":"6","author":"Yamaguchi","year":"1993","journal-title":"Baillier. Clin. Haematol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","article-title":"Phase I Study of KW-0761, a defucosylated humanized Anti-CCR4 Antibody, in relapsed patients with adult T-Cell leukemia-lymphoma and peripheral T-Cell lymphoma.","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.bbmt.2019.12.004","article-title":"Outcomes of allogeneic hematopoietic stem cell transplantation for ATL with HTLV-1 antibody positive donors: allo-HCT for ATL from HTLV-1antibody positive donors.","volume":"6","author":"Yoshimitsu","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/s41409-018-0400-5","article-title":"A retrospective analysis of haplo-identical HLA-mismatch hematopoietic transplantation without posttransplantation cyclophosphamide for GVHD prophylaxis in patients with adult T-cell leukemia-lymphoma.","volume":"54","author":"Yoshimitsu","year":"2018","journal-title":"Bone Marrow Transplant."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.01207\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T07:06:41Z","timestamp":1592550401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.01207\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":78,"alternative-id":["10.3389\/fmicb.2020.01207"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.01207","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,19]]},"article-number":"1207"}}